Glenmark Pharmaceuticals Ltd. has informed that at the meeting of the Board of Directors of the company held on October 29, 2015, Mr. Milind Sarwate has been appointed as an Additional Director of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,030 INR | +1.02% | +1.72% | +20.45% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.45% | 3.53B | |
+21.64% | 44.12B | |
+22.22% | 22.61B | |
+18.22% | 15.11B | |
+13.86% | 13.61B | |
+60.80% | 13.34B | |
-8.98% | 6.94B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.75B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Ltd Appoints Milind Sarwate as Additional Director